Detection and prognosis of recurrent gastric cancer--is routine follow-up after gastrectomy worthwhile?
- PMID: 11100384
Detection and prognosis of recurrent gastric cancer--is routine follow-up after gastrectomy worthwhile?
Abstract
Background/aims: Although routine follow-up after surgery for gastric cancer is recommended its value after gastrectomy has not been evaluated.
Methodology: All patients who underwent gastrectomy for gastric cancer entering the routine follow-up program between January 1987 and August 1996 were identified. The patients studied were those with either histologically proven recurrence or those in whom recurrence was highly probable from clinical course. Two groups were compared. The first group comprised the patients whose recurrence was detected by routine follow-up prior to the development of clinical signs (asymptomatic group). The second group consisted of the patients who developed clinical symptoms due to a recurrence that was detected subsequently (symptomatic group). The main parameters were the time until recurrence occurred, the pattern of recurrence, treatment and survival.
Results: Out of 184 patients entering the routine follow-up 135 patients had undergone potentially curative gastrectomy. Sixty-seven patients (49.6%) had recurrences. Only 15 (22.3%) belonged to the asymptomatic group and 52 (77.7%) to the symptomatic one. The time until recurrence occurred was not different between the 2 groups (17.1 vs. 18.0 months). Chemotherapy was performed more frequently in the asymptomatic group and survival was longer (8.4 vs. 5.9 months). This difference was due to the time the patients remained asymptomatic (average 43 months). No effect of either early detection or chemotherapy was seen. In the asymptomatic group distant recurrence was common while recurrence in the symptomatic group was more often local but this difference did not reach statistic significance.
Conclusions: Routine follow-up after gastrectomy for gastric cancer does not contribute to early detection of gastric cancer recurrence. It has no benefit with respect to treatment and survival of patients with recurrent disease and should therefore be reduced to symptomatic and psychological aftercare.
Similar articles
-
Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: a 15-year follow-up study at a single korean institute.Ann Surg Oncol. 2007 Oct;14(10):2730-7. doi: 10.1245/s10434-007-9479-4. Epub 2007 Jul 14. Ann Surg Oncol. 2007. PMID: 17632757
-
Is detection of asymptomatic recurrence after curative resection associated with improved survival in patients with gastric cancer?J Am Coll Surg. 2005 Oct;201(4):503-10. doi: 10.1016/j.jamcollsurg.2005.05.033. J Am Coll Surg. 2005. PMID: 16183487
-
The prognostic value of detecting symptomatic or asymptomatic recurrence in patients with gastric cancer after a curative gastrectomy.J Surg Res. 2013 Mar;180(1):e1-9. doi: 10.1016/j.jss.2012.03.035. Epub 2012 Apr 11. J Surg Res. 2013. PMID: 22520575
-
259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.Breast Cancer Res Treat. 2008 Jun;109(3):405-16. doi: 10.1007/s10549-007-9668-7. Epub 2007 Aug 9. Breast Cancer Res Treat. 2008. PMID: 17687650 Review.
-
Cost-benefit of follow-up after total gastrectomy.Hepatogastroenterology. 1989 Aug;36(4):266-72. Hepatogastroenterology. 1989. PMID: 2509317 Review.
Cited by
-
Time to death and pattern of death in recurrence following curative resection of gastric carcinoma: analysis based on depth of invasion.World J Surg. 2004 Sep;28(9):866-9. doi: 10.1007/s00268-004-7359-7. World J Surg. 2004. PMID: 15593458
-
Improved outcome in asymptomatic recurrence following curative surgery for gastric cancer.Med Oncol. 2011 Dec;28(4):973-80. doi: 10.1007/s12032-010-9576-2. Epub 2010 Jun 2. Med Oncol. 2011. PMID: 20517658
-
Follow-up of gastric cancer: a review.Gastric Cancer. 2006;9(2):74-81. doi: 10.1007/s10120-006-0360-0. Gastric Cancer. 2006. PMID: 16767361 Review.
-
Prognostic impact of dissected lymph node count on patients with node-negative gastric cancer.World J Gastroenterol. 2009 Aug 21;15(31):3926-30. doi: 10.3748/wjg.15.3926. World J Gastroenterol. 2009. PMID: 19701974 Free PMC article.
-
Computed tomography-guided permanent brachytherapy for locoregional recurrent gastric cancer.Radiat Oncol. 2012 Jul 24;7:114. doi: 10.1186/1748-717X-7-114. Radiat Oncol. 2012. PMID: 22827960 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Medical